Home - Products - Others - Other Targets - 2,3-dihydroxy-4,4-dimethoxychalcone

2,3-dihydroxy-4,4-dimethoxychalcone

CAS No. 2567-65-9

2,3-dihydroxy-4,4-dimethoxychalcone( ——— )

Catalog No. M39411 CAS No. 2567-65-9

3,2'-Dihydroxy-4,4'-dimethoxychalcone is a Chalcones product that can be isolated from the resins of Xanthorrhoea hastilis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 581 In Stock
25MG Get Quote In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    2,3-dihydroxy-4,4-dimethoxychalcone
  • Note
    Research use only, not for human use.
  • Brief Description
    3,2'-Dihydroxy-4,4'-dimethoxychalcone is a Chalcones product that can be isolated from the resins of Xanthorrhoea hastilis.
  • Description
    3,2'-Dihydroxy-4,4'-dimethoxychalcone is a Chalcones product that can be isolated from the resins of Xanthorrhoea hastilis.
  • In Vitro
    ———
  • In Vivo
    ———
  • Synonyms
    ———
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ———
  • Indication
    ———

Chemical Information

  • CAS Number
    2567-65-9
  • Formula Weight
    300.31
  • Molecular Formula
    C17H16O5
  • Purity
    >98% (HPLC)
  • Solubility
    ———
  • SMILES
    ———
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Momordin II

    Momordin II, an oleanane-type triterpene glycoside, is a ribosome inactivating protein. Momordin II inhibits cell-free protein synthesis, releases adenine from rat liver ribosomes and from DNA, and has no RNase activity.

  • Guanine

    Guanine is a purine base that is a constituent of nucleotides occurring in nucleic acids.

  • Ingenol

    Ingenol mebutate is an effective treatment for actinic keratosis. 2. Formulating novel derivatives from Ingenol esters may be an innovative approach to develop new lead compounds to reactivate latent HIV.